D.B.S. has consulted/received honoraria from Rain, Pfizer, Fog Pharma, PaigeAI, BridgeBio, Scorpion Therapeutics, FORE Therapeutics, Function Oncology, Pyramid and Elsie Biotechnologies, Inc. None of these disclosures are directly related to this study. The other authors declare no competing ...